The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

NCT00588705 | Completed

• 1 other identifier: 07-063
• Study Type: observational
• Target: 27
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters. A second part of the study asks women for their opinions about when and how their daughters should be told about any genetic risks. All of this will help us develop teaching methods to help our doctors improve the way they talk about genetic risk when women with breast cancer have adolescent daughters.

Conditions

Breast Cancer; Counseling

Keywords

Daughters; Communication; genetic risk; Genetic Counseling

Outcome Measures

Primary Outcomes (1)

• Is a demonstration of the effectiveness of the module in changing the behavior of clinicians after taking part in the communication skills module.

  conclusion of study

Secondary Outcomes (1)

• To examine the views of women about the provision of genetic risk information to their daughters.

  conclusion of study

Study Arms (1)

focus group & questionaire

The group will discuss its views about how and when to talk about the risk of getting breast cancer. The focus group will be video recorded and the video recorded material will be later transcribed and carefully analyzed. In addition you will be asked to answer questions about yourself, such as education and marital status.

Behavioral: focus group & questionaire

Interventions

focus group & questionaire BEHAVIORAL

The focus group will last about 90 minutes. However, your involvement in this study will last from the time you join until you read over the summary of what happened during the focus group and return your comments. This should be approximately 2 months. Patient will complete a questionnaire and we estimate total time for completion to be approximately 7 minutes.

focus group & questionaire

Eligibility Criteria

• Age: 12 Years - 20 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Memorial Sloan-Kettering Cancer Center (MSK) breast cancer patients seen by the clinical genetics service (CGS)and their daughters

You may qualify if:

• Women seen in the MSK CGS Service who have a diagnosis of breast cancer or
• a family history of breast cancer and
• have biological daughter(s) in the age range 12-20 years will be eligible to participate in Phase I \& II.
• Women who were consented to Phase I will automatically be eligible for Phase II.

You may not qualify if:

• Women seen in the MSK CGS Service will be ineligible if they have no diagnosis of breast cancer and no family history of breast cancer,
• do not have a biological daughter,
• or have a biological daughter fewer than 12 or greater than 20 years(unless they were consented to Phase 1).
• Women will be ineligible if they are not English speaking,
• have intellectual or cognitive impairment,
• or active mental illness rendering them incapable of giving informed consent, such as might occur with active psychosis.

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead
• Monash University: collaborator

Study Sites (1)

Memorial Sloan-Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

• Memorial Sloan-Kettering Cancer Center

MeSH Terms

Conditions

Breast Neoplasms; Communication

Interventions

Focus Groups

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Behavior

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Smita Banerjee, PhD

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: FAMILY BASED
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 24, 2007
• First Posted: January 8, 2008
• Study Start: December 1, 2007
• Primary Completion: January 1, 2017
• Study Completion: January 1, 2017
• Last Updated: January 30, 2017

Record last verified: 2017-01

Locations

US (1)